PASQUINI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 1.097
EU - Europa 300
AS - Asia 293
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
SA - Sud America 1
Totale 1.696
Nazione #
US - Stati Uniti d'America 1.092
IT - Italia 174
CN - Cina 100
SG - Singapore 93
ID - Indonesia 49
TR - Turchia 39
DE - Germania 27
GB - Regno Unito 24
UA - Ucraina 22
PL - Polonia 21
SE - Svezia 12
FI - Finlandia 8
FR - Francia 6
CA - Canada 4
CZ - Repubblica Ceca 3
KR - Corea 3
EG - Egitto 2
EU - Europa 2
HK - Hong Kong 2
PK - Pakistan 2
TW - Taiwan 2
BR - Brasile 1
CH - Svizzera 1
IR - Iran 1
JP - Giappone 1
MX - Messico 1
NZ - Nuova Zelanda 1
RO - Romania 1
RU - Federazione Russa 1
VN - Vietnam 1
Totale 1.696
Città #
Fairfield 165
Woodbridge 107
Chandler 104
Ashburn 80
Houston 79
Seattle 70
Singapore 69
Cambridge 55
Ferrara 51
Jakarta 49
Wilmington 46
Ann Arbor 37
Milan 36
Shanghai 30
Izmir 28
Jacksonville 28
Princeton 27
Beijing 26
Los Angeles 25
Warsaw 20
Santa Clara 13
Nanjing 11
San Diego 10
Falls Church 9
London 9
Ferrara di Monte Baldo 8
Boardman 7
Bologna 7
San Antonio 7
Munich 6
Venice 6
Nanchang 5
Cagliari 4
Jiaxing 4
Mountain View 4
Redwood City 4
Aversa 3
Brno 3
Changsha 3
Des Moines 3
Genoa 3
New York 3
Northampton 3
Verona 3
Boston 2
Bremen 2
Buffalo 2
Changchun 2
Clifton 2
Frankfurt am Main 2
Hebei 2
Hong Kong 2
Islamabad 2
Missoula 2
New Bedfont 2
Norwalk 2
Pisa 2
Redmond 2
Reggio Emilia 2
Saskatoon 2
Shenyang 2
Tianjin 2
Torino 2
Trieste 2
Wandsworth 2
Auckland 1
Campina Grande 1
Canary Wharf 1
Chicago 1
Chiswick 1
Crevalcore 1
Damanhur 1
Dearborn 1
Dong Ket 1
Florence 1
Garden City 1
Gdansk 1
Haikou 1
Helsinki 1
Ismailia 1
Istanbul 1
Kashan 1
Kilburn 1
Kyoto 1
Lappeenranta 1
Markham 1
Marseille 1
Moscow 1
Neunkirchen 1
Ningbo 1
Oklahoma City 1
Orange 1
Orléans 1
Paris 1
Pasadena 1
Querétaro 1
Savignano sul Rubicone 1
Seoul 1
Taipei 1
Tappahannock 1
Totale 1.347
Nome #
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 146
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 128
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 120
Design, Synthesis, and Pharmacological Characterization of Indol-3-ylacetamides, Indol-3-yloxoacetamides, and Indol-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists 111
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 108
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 98
Development of novel pyridazinone-based adenosine receptor ligands 87
Modifications on the amino-3,5-dicyanopyridine core to obtain multifaceted adenosine receptor ligands with antineuropathic activity 81
The role of adenosinergic system in brain ischemia 64
Amino-3, 5-dicyanopyridines targeting the adenosine receptors ranging from pan ligands to combined A1/A2B partial agonists 62
Structural investigation on thiazolo[5,4-d]pyrimidines to obtain dual-acting blockers of CD73 and adenosine A2A receptor as potential antitumor agents 53
The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A1AR Positive Allosteric Modulation 53
Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1and A2A adenosine receptor antagonists/inverse agonists 49
Structure-activity relationship studies and pharmacological characterization of N5-heteroarylalkyl-substituted-2-(2-furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine-based derivatives as inverse agonists at human A2Aadenosine receptor 48
A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma 42
A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic? 41
Adenosinergic System Involvement in Ischemic Stroke Patients' Lymphocytes 38
Pulsed Electromagnetic Field Stimulation in Osteogenesis and Chondrogenesis: Signaling Pathways and Therapeutic Implications 38
Adenosine and inflammation: Here, there and everywhere 35
Targeting adenosine receptors: A potential pharmacological avenue for acute and chronic pain 34
Piperazine-and piperidine-containing thiazolo[5,4-d]pyrimidine derivatives as new potent and selective adenosine a2a receptor inverse agonists 34
An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment? 31
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease 30
Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer's Disease 26
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition 25
Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets 25
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity? 24
4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives 24
Pulsed electromagnetic fields stimulate hif-1α-independent vegf release in 1321n1 human astrocytes protecting neuron-like sh-sy5y cells from oxygen-glucose deprivation 21
Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications 18
Synthesis of Unsymmetrical Squaramides as Allosteric GSK-3β Inhibitors Promoting β-Catenin-Mediated Transcription of TCF/LEF in Retinal Pigment Epithelial Cells 16
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 16
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? 15
Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy 14
Pharmacology of Adenosine Receptors: Recent Advancements 13
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors 10
2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A1 Adenosine Receptor Positive Allosteric Modulators 8
Pioneering first-in-class FAAH-HDAC inhibitors as potential multitarget neuroprotective agents 7
Binding and unbinding of potent melatonin receptor ligands: Mechanistic simulations and experimental evidence 4
Totale 1.797
Categoria #
all - tutte 13.927
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.927


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020204 0 0 0 29 17 25 33 26 27 21 18 8
2020/2021347 9 8 5 14 17 23 86 48 30 58 39 10
2021/2022228 10 14 13 0 5 17 27 20 16 18 44 44
2022/2023286 29 48 4 27 23 20 43 22 24 9 23 14
2023/2024235 17 14 9 6 38 13 11 24 7 13 10 73
2024/2025217 39 62 116 0 0 0 0 0 0 0 0 0
Totale 1.797